Octofactor (moroctocog alfa biosimilar)
/ Generium
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 19, 2023
Hemorrhagic Complications in Patients with Hemophilia A
(ISTH 2023)
- "A prospective, randomized studyThe follow-up period was 12 weeks. In the first group, 61 cases of hemorrhagic episodes were registered. Posttraumatic 15 (24,5%), spontaneous - 46 (75,4%)."
Clinical • Hematological Disorders • Hemophilia • Osteoarthritis • Rare Diseases
December 05, 2017
Newly added product
(Generium Press Release)
Pipeline update • Hematological Malignancies • Hemophilia • Oncology
1 to 2
Of
2
Go to page
1